B. Riley Reiterates Buy Rating for Eton Pharmaceuticals (NASDAQ:ETON)
B. Riley reissued their buy rating on shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) in a research report released on Friday morning,Benzinga reports. The firm currently has a $26.00 price objective on the stock, up from their prior price objective of $24.00. B. Riley also issued estimates for Eton Pharmaceuticals’ Q3 2025 earnings at […]
B. Riley reissued their buy rating on shares of Eton Pharmaceuticals (NASDAQ:ETON – Free Report) in a research report released on Friday morning,Benzinga reports. The firm currently has a $26.00 price objective on the stock, up from their prior price objective of $24.00. B. Riley also issued estimates for Eton Pharmaceuticals’ Q3 2025 earnings at […]
